Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/1995
10/04/1995EP0674632A1 Aminoacid derivatives of heterocycles as protein kinase c inhibitors
10/04/1995EP0674631A1 Substituted pyrazoles as crf antagonists
10/04/1995EP0674625A1 Amino-substituted pyrazoles having crf antagonistic activity
10/04/1995EP0674624A1 Pyrazoles and pyrazolopyrimidines having crf antagonist activity
10/04/1995EP0674516A1 Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds
10/04/1995EP0674505A1 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails
10/03/1995US5455275 Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
10/03/1995US5455274 Leukotriene antagonists; treating rheumatoid arthritis
10/03/1995US5455258 Useful as inhibitors of matrix-degrading metalloproteinase enzymes such as stromelysin and/or collegenase
10/03/1995US5455252 Optionally substituted 6,8-quinolines
10/03/1995US5455233 Detectors, antiinflammatory, antilipemic agents and antitumor agents
10/03/1995US5455232 Pharmaceutical preparation based on rhamnolipid
10/03/1995CA1337202C Cyclic amides which are leukotriene antagonists
10/03/1995CA1337175C Use of zofenopril for the treatment of rheumatoid arthritis
09/1995
09/28/1995WO1995025814A1 Oligonucleotide n3'→p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties
09/28/1995WO1995025795A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS
09/28/1995WO1995025741A1 Gnrh antagonists
09/28/1995WO1995025718A1 Vitamin-d amide derivatives
09/28/1995WO1995025543A1 Methods and compositions useful for inhibition of angiogenesis
09/28/1995WO1995025533A1 PROTEASOME REGULATION OF NF-λB ACTIVITY
09/28/1995WO1995025531A1 Means for treating auto-immune diseases and method of treatment
09/28/1995WO1995023806A3 Ureido derivatives of naphthalenephosphonic acids and process for their preparation
09/28/1995CA2185892A1 Means for treating auto-immune diseases and method of treatment
09/28/1995CA2185813A1 Vitamin-d amide derivatives
09/28/1995CA2185710A1 Gnrh antagonists
09/27/1995EP0673933A1 Aminoalkyl benzoxazolinones and benzothiazolinones process for their preparation and compositions containing them
09/27/1995EP0673928A1 Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists
09/27/1995EP0673646A2 Use of Deoxypergualin in the manufacture of a medicament for the treatment of inflammatory-hyperresponsiveness diseases
09/27/1995EP0673426A1 Platelet-activating factor acetylhydrolase
09/27/1995EP0673367A1 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperidines as tachykinin receptor antagonists
09/27/1995EP0673366A1 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
09/27/1995EP0673245A1 Effervescent pharmaceutical composition containing ibuprofen and method for preparing same.
09/27/1995EP0673241A1 A free radical quenching liposomal composition
09/27/1995EP0616525B1 Pharmaceutical aerosol formulation
09/27/1995EP0549621B1 New leukotriene-b4 antagonists, process for producing the same and their use as medicinal drugs
09/27/1995EP0529022B1 New leukotriene b 4? derivatives, method for preparing them and their use as drugs
09/27/1995EP0526535B1 Cyclic hydroxamic acids and their use
09/27/1995EP0311677B1 Cough/cold mixtures comprising non-sedating antihistamine drugs
09/27/1995CN1108934A Pharmaceutical compositions and usages
09/27/1995CN1029846C Compounds for treating inflammatory bowel disease
09/26/1995US5453439 Hydroxylamine derivatives
09/26/1995US5453423 Respiratory system disorders
09/26/1995US5453272 Serine-proline-tyrosine-glycine-arginine-cysteine hexapeptide; immunosuppressant
09/26/1995CA1337122C Pharmacologically active 1,5-diaryl-3-substituted-pyrazoles and method for synthesizing the same
09/23/1995CA2145026A1 Aminoalkyl benzoxazolinones and benzothiazolinones; process for preparing the same and pharmaceutical compositions containing them
09/21/1995WO1995025128A1 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same
09/21/1995WO1995024920A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
09/21/1995WO1995024915A1 Product and process for regulating signal transduction pathways
09/21/1995WO1995022974A3 Film coated tablet of paracetamol and domperidone
09/21/1995WO1995021601A3 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
09/21/1995WO1995018826A3 Purified primate ctla-8 antigens and related reagents
09/21/1995CA2185663A1 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same
09/21/1995CA2185324A1 Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
09/21/1995CA2184631A1 Product and process for regulating signal transduction pathways
09/20/1995EP0672414A2 Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen
09/20/1995EP0672180A1 Oligonucleotide modulation of protein kinase c
09/20/1995EP0672152A1 Fusion proteins comprising mgf and il-3
09/20/1995EP0672151A1 Inhibitors of ced-3 and related proteins
09/20/1995EP0672144A1 Interleukin-6 receptor antagonists
09/20/1995EP0672143A1 LYMPHOTOXIN-$g(b), LYMPHOTOXIN-$g(b) COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF
09/20/1995EP0672041A1 Pharmacologically active pyridine derivatives and processes for the preparation thereof
09/20/1995EP0672031A1 Catechol diethers as selective pde iv? inhibitors
09/20/1995EP0672030A1 Process for preparing substantially pure enantiomers of phenylpropionic acids.
09/20/1995EP0671951A1 Humanized antibodies reactive with l-selectin
09/20/1995EP0671941A1 Bradykinin antagonists
09/20/1995EP0671933A1 Novel uses of il-10
09/20/1995EP0671927A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus
09/20/1995EP0671911A1 Carboxy-peptidyl derivatives as antidegenerative active agents
09/20/1995EP0364559B1 Substituted adenine derivatives useful as therapeutic agents
09/20/1995CN1108661A Corticoid 17,21-dicarboxylic esters and corticosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds
09/19/1995US5451586 Substance P antagonist
09/19/1995US5451518 Purified human ceramide-activated protein kinase
09/19/1995US5451399 [ALA IL-8]77 and [SER IL-8]72 as Leukocyte adhesion inhibitors
09/19/1995CA1337072C 5-substituted [4,5-c] imidazopyridines
09/16/1995CA2144591A1 Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen
09/14/1995WO1995024501A1 Compositions for the inhibition of tnf formation and uses thereof
09/14/1995WO1995024473A1 Vascular endothelial growth factor 2
09/14/1995WO1995024437A1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents
09/14/1995WO1995024422A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995WO1995024416A1 Novel silyl compounds and their use
09/14/1995WO1995024408A1 Benzothiophene, benzofuran and indolethiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv
09/14/1995WO1995024398A1 Isoxazoline compounds as inhibitors of tnf release
09/14/1995WO1995024397A1 3,5-disubstituted and 3,5,6-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments
09/14/1995WO1995024395A1 Quinoline derivatives as immunomodulators
09/14/1995WO1995024381A1 Cyano compounds and preparations thereof
09/14/1995WO1995024209A1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products
09/14/1995WO1995024208A1 Glioblastoma-derived angiogenesis inhibiting factor
09/14/1995WO1995024207A1 Composition for the treatment of lung disease
09/14/1995WO1995024192A1 Isoxazoline compounds as 5-lipoxygenase inhibitors
09/14/1995DE4408084A1 3,5-Disubstituierte und 3,4,5-trisubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel 3,5-Disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles, to processes for their preparation and their use as medicaments
09/14/1995CA2414016A1 Vascular endothelial growth factor 2
09/14/1995CA2214521A1 Quinoline derivatives as immunomodulators
09/14/1995CA2185229A1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents
09/14/1995CA2185162A1 Compositions for the inhibition of tnf formation and uses thereof
09/14/1995CA2185004A1 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles, process for preparing the same and their use as medicaments
09/14/1995CA2184824A1 Bradykinin antagonist peptides incorporating n-substituted glycines
09/14/1995CA2184385A1 Composition for the treatment of lung disease
09/14/1995CA2184358A1 Glioblastoma-derived angiogenesis inhibiting factor
09/14/1995CA2181354A1 Benzothiophene, benzofuran and indole-thiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv
09/13/1995EP0671409A2 Malonic acid derivatives having anti-adhesive properties